SCHEMBL24319338

SCHEMBL24319338

CN1CCC(CN2CC(C3(C)CC3)C2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 1/20 0.46
SCN4A P35499 1/20 0.46
SCN7A Q01118 1/20 0.46
KCNH2 Q12809 1/20 0.46
SCN5A Q14524 1/20 0.46
SCN9A Q15858 1/20 0.46
SCN2A Q99250 1/20 0.46
SCN3A Q9NY46 1/20 0.46
SCN11A Q9UI33 1/20 0.46
SCN8A Q9UQD0 1/20 0.46
SCN10A Q9Y5Y9 1/20 0.46
SIGMAR1 Q99720 9/20 0.41
NCF1 P14598 1/20 0.39
CACNA2D1 P54289 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNB1 Q02641 1/20 0.33
CACNA1C Q13936 1/20 0.33
ACHE P22303 1/20 0.32
CHRM5 P08912 1/20 0.31
ADRA2C P18825 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24319185 0.86 NCF1 (0.39) SCN1ASCN4ASCN7AKCNH2SCN5A
SCHEMBL24319649 0.83 SIGMAR1 (0.42) SCN1ASCN4ASCN7AKCNH2SCN5A
SCHEMBL24319167 0.83 SIGMAR1 (0.42) SCN1ASCN4ASCN7AKCNH2SCN5A
SCHEMBL24832947 0.76 NCF1 (0.43) SCN1ASCN4ASCN7AKCNH2SCN5A
SCHEMBL24319509 0.75 ACHE (0.35) SCN1ASCN4ASCN7AKCNH2SCN5A
SCHEMBL22703778 0.75 NCF1 (0.46) SCN1ASCN4ASCN7AKCNH2SCN5A
SCHEMBL14431948 0.74 KMT2A (0.40) KCNH2NCF1KMT2A
SCHEMBL23173902 0.74 NCF1 (0.54) KCNH2SIGMAR1NCF1CACNA2D1CACNA1B
SCHEMBL17033031 0.74 NCF1 (0.37) KCNH2NCF1KMT2A
SCHEMBL25571706 0.74 NCF1 (0.54) KCNH2SIGMAR1NCF1CACNA2D1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed